US Patent Issued to Genentech on Jan. 20 for "Pyrazolopyrimidine aryl ether inhibitors of JAK kinases and uses thereof" (American, Chinese Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,812, issued on Jan. 20, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Pyrazolopyrimidine aryl ether inhibitors of JAK kinases and uses thereof" was invented by Mark Edward Zak (Davidsonville, Md.), Naomi S. Rajapaksa (San Mateo, Calif.), Yun-Xing Cheng (Beijing), Wei Li (Beijing), Daniel G.M. Shore (Redwood City, Calif.), F. Anthony Romero (Redwood City, Calif.) and Marian C. Bryan (Fort Washington, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds and salts thereof that are useful as JAK kinase inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceu...